TFE3 and renal cell carcinoma: TFE3-rearranged Renal Cell Carcinoma (TFE3-RCC) is a distinct subset of RCC, defined in the 2022 WHO classification, characterized by Xp11.2 rearrangements that result in TFE3 gene fusions with various partner genes [1,2,3].